ArticleBiomedical optics express2025
Enhancing the pathological diagnosis of oral cancers using broadband ultraviolet photoacoustic microscopy.
Article in Biomedical optics express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Introduction to the feature issue Photoacoustic Imaging and Sensing: Beyond Fundamentals to Translation.Biomedical optics express · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Conventional histopathological diagnostic methods, such as hematoxylin-eosin (H&E) staining and immunohistochemistry (IHC), face significant challenges in intraoperatively diagnosing early-stage oral cancer and certain cancer types. To address this, we propose a novel pathological diagnostic method based on a broadband ultraviolet photoacoustic microscope (bUV-PAM). This method capitalizes on the unique optical absorption properties of nuclei and high-frequency photoacoustic spectral variations, enabling the simultaneous performance of photoacoustic morphological imaging (PAMI) and photoacoustic spectral analysis (PASA) within 20 minutes. As a result, photoacoustic images of normal and cancerous mouse tissues, including oral squamous cell carcinoma (OSCC) and adenoid cystic carcinoma (ACC), demonstrate strong consistency with their corresponding H&E images. Moreover, the photoacoustic spectral profiles of these tissues exhibit significant differences, validating the effectiveness of PASA in differentiating between normal and cancerous states. Furthermore, PASA rapidly identifies diseases that are challenging to diagnose with H&E staining, such as the transition from normal mouse mucosa tissue to OSCC and the differentiation between OSCC and ACC, as verified by the more time-consuming IHC method. Consequently, the photoacoustic pathological diagnosis method enhances current diagnostic practices, promising to offer crucial support for the rapid intraoperative identification of human early-stage oral cancers and various cancer types.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.